851 participants
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-03
- Start Date:
- 2024-06-10
- Completion:
- 2029-01-12
Conditions
- Non-small Cell Lung Cancer
- NSCLC
Interventions
- BIOLOGICAL
- DRUG
No Results Yet